FTLF trades 170.6% below Wall Street's consensus target of $30.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes FTLF achieves its forward estimates and maintains a stable P/E multiple of 13.1x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, FitLife Brands, Inc. (FTLF) has a Wall Street consensus price target of $30.50, based on estimates from 2 covering analysts. With the stock currently trading at $10.83, this represents a potential upside of +170.6%. The company has a market capitalization of $102M.
Analyst price targets range from a low of $21.00 to a high of $40.00, representing a 62% spread in expectations. The median target of $30.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, FTLF trades at a trailing P/E of 17.2x and forward P/E of 13.1x. Analysts expect EPS to grow +42.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $16.55, with bear and bull scenarios of $10.43 and $21.81 respectively. Model confidence stands at 40/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
SMPLThe Simply Good Foods Company | $1.2B | $11.84 | $15.00 | +18.8% | Buy | 7.6x | 24 |
MGPIMGP Ingredients, Inc. | $347M | $16.25 | $29.00 | +76.4% | Buy | 10.3x | 14 |
HIMSHims & Hers Health, Inc. | $7.4B | $33.54 | $28.08 | -20.8% | Hold | — | 20 |
PLNTPlanet Fitness, Inc. | $4.1B | $51.06 | $77.88 | +47.0% | Buy | 16.6x | 29 |
VITLVital Farms, Inc. | $432M | $10.08 | $12.86 | +23.5% | Buy | — | 16 |
CELHCelsius Holdings, Inc. | $7.4B | $29.12 | $52.83 | +71.5% | Buy | 18.7x | 23 |
MNSTMonster Beverage Corporation | $91.0B | $93.02 | $90.58 | -0.8% | Buy | 39.9x | 44 |
LFVNLifeVantage Corporation | $77M | $6.08 | $5.00 | -22.0% | Hold | 11.2x | 3 |
NTRBNutriband Inc. | $38M | $3.11 | — | — | — | — | — |
USPHU.S. Physical Therapy, Inc. | $952M | $62.51 | $96.00 | +51.6% | Buy | 21.9x | 13 |
Quick answers to the most common questions about buying FTLF stock.
The consensus Wall Street price target for FTLF is $30.5, representing 170.6% upside from the current price of $10.83. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
FTLF has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $30.5 implies 170.6% upside from current levels.
With a forward P/E of 13.1047x, FTLF trades at a relatively low valuation. The consensus target of $30.5 implies 170.6% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $40 for FTLF, while the most conservative target is $21. The consensus of $30.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $22 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
FTLF is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month FTLF stock forecast based on 2 Wall Street analysts shows a consensus price target of $30.5, with estimates ranging from $21 (bear case) to $40 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $17, with bear/bull scenarios of $10/$22.
Our quantitative valuation model calculates FTLF's fair value at $17 (base case), with a bear case of $10 and bull case of $22. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.
FTLF trades at a forward P/E ratio of 13.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on FTLF, with a "Buy" consensus rating and $30.5 price target (170.6% upside). 2 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
FTLF analyst price targets range from $21 to $40, a 62% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $30.5 consensus represents the middle ground. Our model's $10-$22 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.